UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 1.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 465,672 shares of the company's stock after acquiring an additional 7,021 shares during the quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC owned about 0.86% of Molina Healthcare worth $153,388,000 at the end of the most recent reporting period.
Other large investors have also recently bought and sold shares of the company. Rothschild Investment LLC raised its holdings in Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after acquiring an additional 48 shares during the period. Zions Bancorporation National Association UT bought a new position in Molina Healthcare in the 1st quarter valued at about $29,000. Deseret Mutual Benefit Administrators raised its holdings in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after acquiring an additional 34 shares during the period. Elequin Capital LP raised its holdings in Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after acquiring an additional 58 shares during the period. Finally, Silver Oak Securities Incorporated bought a new position in shares of Molina Healthcare during the first quarter worth approximately $34,000. 98.50% of the stock is owned by institutional investors.
Insider Buying and Selling
In related news, COO James Woys bought 10,000 shares of the business's stock in a transaction on Monday, August 4th. The shares were purchased at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the completion of the transaction, the chief operating officer directly owned 74,331 shares of the company's stock, valued at approximately $11,591,176.14. This represents a 15.54% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Ronna Romney sold 700 shares of the firm's stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the completion of the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. This represents a 3.93% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.10% of the company's stock.
Molina Healthcare Stock Performance
Shares of NYSE:MOH opened at $180.59 on Friday. The company's 50 day simple moving average is $179.44 and its 200 day simple moving average is $266.19. The stock has a market capitalization of $9.79 billion, a price-to-earnings ratio of 8.90 and a beta of 0.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. Molina Healthcare, Inc has a 1 year low of $151.95 and a 1 year high of $365.23.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The firm had revenue of $11.43 billion during the quarter, compared to the consensus estimate of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The business's revenue was up 15.7% compared to the same quarter last year. During the same period last year, the business earned $5.86 earnings per share. As a group, research analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
MOH has been the topic of several recent research reports. UBS Group lowered their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating on the stock in a report on Friday, July 25th. Sanford C. Bernstein lowered their target price on shares of Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating on the stock in a report on Friday, September 5th. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $210.00 target price on shares of Molina Healthcare in a report on Tuesday, August 26th. Morgan Stanley cut shares of Molina Healthcare from an "overweight" rating to an "equal weight" rating and lowered their target price for the stock from $364.00 to $266.00 in a report on Thursday, July 10th. Finally, Barclays lowered their target price on shares of Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating on the stock in a report on Thursday, September 4th. Three equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $225.18.
Get Our Latest Stock Analysis on Molina Healthcare
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.